CA HEALTHCARE ACQUISITION CORP.

Inactive Instrument

Highlights CA Healthcare Acquisition Corp.

Equities

CAHC

US12510W1071

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

CA HEAL25 : Underwriting Agreement - Form 6-K	16/08/22	PU
CA Healthcare Acquisition : LumiraDx Close $3 Billion SPAC Merger	29/09/21	MT
CA Healthcare Acquisition : LumiraDx to Become Publicly Traded following Successful Closing of Merger with CA Healthcare Acquisition Corp.	28/09/21	BU
LumiraDx Ltd completed the acquisition of CA Healthcare Acquisition Corp. from CA Healthcare Sponsor LLC and others in a reverse merger transaction.	27/09/21	CI
CA Healthcare Acquisition : to Hold Special Shareholder Meeting Sept. 28 Regarding LumiraDx Deal	07/09/21	MT
CA Healthcare Acquisition : Latest Investor Presentation	02/09/21	PU
CA Healthcare Acquisition : TO THE AGREEMENT AND PLAN OF MERGER (Form 8-K)	30/08/21	PU
CA Healthcare Acquisition : LumiraDx Lower Enterprise Value of Potential Combined Entity to $3 Billion From $5 Billion	20/08/21	MT
CA Healthcare Acquisition : Amendment to Quarterly Report (SEC Filing - 10-Q/A)	26/05/21	PU
Ca Healthcare Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	25/05/21	CI
CA Healthcare Acquisition : Secures Deal to Merge With Point-Of-Care Diagnostics Firm LumiraDx	07/04/21	MT
CA Healthcare Acquisition : LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp	07/04/21	BU
LumiraDx Ltd entered into a definitive merger agreement to acquire CA Healthcare Acquisition Corp. from CA Healthcare Sponsor LLC and others in a reverse merger transaction.	06/04/21	CI
CA Healthcare Acquisition Corp. has completed an IPO in the amount of $100 million.	26/01/21	CI
CA Healthcare Acquisition Corp. has filed an IPO in the amount of $100 million.	08/01/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer